[Results of the treatment of lymphatic neoplasms with Vepeside].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D005047:Etoposide / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013997:Time Factors
D005047:Etoposide; D011034:Podophyllotoxin
Wyniki leczenia Vepesidem chorych na nowotwory limfatyczne.